Results for erythropoietin translation from Danish to English

erythropoietin
erythropoietin

naturlige hormon, erythropoietin
of the natural hormone erythropoietin

erythropoietin dannes i nyrerne.
erythropoietin is produced by the kidneys.

forsøgspersoner randomiseret til erythropoietin (n=251)
subjects randomized to receive erythropoietin (n=251)

er human erythropoietin, og patienterne i kontrolgruppen.
overall survival outcome in the trials could ng not be satisfactorily explained by differences in the incidence of thrombosis and related complications between those given recombinant human erythropoietin and those in the control group. lo

den terapeutiske margin for erythropoietin er meget bred.
the therapeutic margin of erythropoietin is very wide.

hvor kroppen producerer for lidt af det naturlige hormon, erythropoietin
the body does not produce enough of the natural hormone erythropoietin,

der kunne ikke detekteres cytotoksiske virkninger af erythropoietin på knoglemarvsceller.
cytotoxic actions of erythropoietin on bone marrow cells could not be detected.

hormonet erythropoietin stimulerer knoglemarven til at producere flere røde blodlegemer.
in patients with long-term kidney failure, the main cause of their anaemia is a lack of natural erythropoietin.

erythropoietin- receptorer kan forekomme på overfladen af en række tumorceller.
erythropoietin receptors may be expressed on the surface of a variety of tumour cells.

til kræfttyper, som modtog rekombinant, human erythropoietin, sammenlignet med kontrolgrupper.
th four placebo-controlled studies the hazard ratios for overall survival ranged between 1.25 and 2.47 in favour of controls.

erythropoietin-receptorer kan være udtrykt i overfladen på en række forskellige tumorceller.
erythropoietin receptors may be expressed on the surface of a variety of tumour cells.

farmakoterapeutisk klassifikation: andre antianæmiske præparater, erythropoietin atc-kode: b03xa01
pharmacotherapeutic group: other antianaemic preparations, erythropoietin atc code: b03xa01

caffein kan undertrykke erythropoietin-syntesen og derved reducere hæmoglobinkoncentrationen ved forlænget behandling.
caffeine may suppress erythropoietin synthesis and hence reduce haemoglobin concentration with prolonged treatment.

aktivt stof: darbepoetin alfa, r-huepo (erythropoietin produceret ved hjælp af genteknologi).
the active substance is darbepoetin alfa, r-huepo (erythropoietin produced by gene technology).

erythropoietins molekylevægt er 32. 000 til 40. 000 dalton.
the apparent molecular weight of erythropoietin is 32,000 to 40,000 dalton.